Clinical Trial Update: Integrated Ultrasound-Derived Fat Fraction and 2D/4D HeartAI for Cardiovascular Risk Management in Patients With MASLD

View source ↗

Summary

A clinical trial update describes using ultrasound-derived fat fraction and 2D/4D HeartAI to manage cardiovascular risk in MASLD patients, with recruitment not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Disease
• Metabolic Dysfunction-associated Steatotic Liver Disease

Snippet

Sponsor: First Affiliated Hospital, Sun Yat-Sen University | Conditions: MASLD, Cardiovascular (CV) Risk | Status: NOT_YET_RECRUITING